Literature DB >> 2357500

Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval.

H Jonsson1, O Nived, G Sturfelt, A Silman.   

Abstract

We studied the age-specific incidence of SLE in a defined population in southern Sweden during 1981-86. Female incidence was 5.4/100,000/year and male incidence 1/100,000/year. In comparison with previous studies, incident cases were characterized by a high age at diagnosis with the highest incidence in age groups 55-64 and 65-74, approximately 7.5/100,000/year. The incidence was low in children under 15 years of age, 0.4/100,000/year, and unexpectedly so in the 15-24 decade, 1.2/100,000/year. Patient retrieval was based on four separate sources: a computerized diagnosis register; referrals from both public health care physicians and private practitioners; and records of ANA positive individuals from the single laboratory serving the area. All incident patients were present in at least two of these sources and 11 patients were present in three. We interpret the high amount of overlap between retrieval sources, without patients detected in only one source, as evidence for a high degree of completeness in our retrieval of SLE patients.

Entities:  

Mesh:

Year:  1990        PMID: 2357500     DOI: 10.1093/rheumatology/29.3.185

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  18 in total

1.  Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.

Authors:  Sudumpai Jarukitsopa; Deana D Hoganson; Cynthia S Crowson; Olayemi Sokumbi; Mark D Davis; Clement J Michet; Eric L Matteson; Hilal Maradit Kremers; Vaidehi R Chowdhary
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

Review 2.  Epidemiology of systemic lupus erythematosus.

Authors:  N Hopkinson
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 3.  [Systemic lupus erythematosus. A problem based approach].

Authors:  S Kleinert; M Feuchtenberger; H-P Tony
Journal:  Internist (Berl)       Date:  2010-08       Impact factor: 0.743

4.  Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.

Authors:  Emily C Somers; Wendy Marder; Patricia Cagnoli; Emily E Lewis; Peter DeGuire; Caroline Gordon; Charles G Helmick; Lu Wang; Jeffrey J Wing; J Patricia Dhar; James Leisen; Diane Shaltis; W Joseph McCune
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

5.  Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Authors:  K Manger; B Manger; R Repp; M Geisselbrecht; A Geiger; A Pfahlberg; T Harrer; J R Kalden
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

6.  A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31.

Authors:  Bo Johanneson; Guadalupe Lima; Jenny von Salomé; Donato Alarcón-Segovia; Marta E Alarcón-Riquelme
Journal:  Am J Hum Genet       Date:  2002-10-08       Impact factor: 11.025

7.  Systemic lupus erythematosus in Saudi patients.

Authors:  S R Alballa
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

8.  Contemporary treatment of systemic lupus erythematosus: an update for clinicians.

Authors:  Maame B Amissah-Arthur; Caroline Gordon
Journal:  Ther Adv Chronic Dis       Date:  2010-07       Impact factor: 5.091

9.  Neuropsychiatric systemic lupus erythematosus in elderly people: a case series.

Authors:  M S Dennis; E J Byrne; N Hopkinson; P Bendall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 10.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.